Innovative technologies and a diverse product pipeline help de-risk product specific execution. Marizyme has focused on large markets including CABG surgery, fat grafting, pet health, and CKD. Access into any and all of these markets provide significant clinical and economic opportunity.

ProductIndicationResearchDevelopmentClinical
Trial
CE MarkedFDA
Approval
group 4549 Vascular Grafts Storage Vascular and Flushing Solution during CABG Surgery        
group 4550 Pet Health - Dental        
group 4550 Measurement of Urine Albumin and Creatinine (ACR)        
group 4550 Measurement of Urine ACR and Blood-Based eGFR